-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Agilon Health, Raises Price Target to $170

Benzinga·11/13/2026 16:30:05
Diffusion vocale
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and raises the price target from $146 to $170.